|
1
|
Kieran MW, Hargrave DR, Cohen KJ, Aerts I, Dunkel IJ, Hummel TR, Jimenez I, Pearson ADJ, Pratilas CA, Whitlock J, Bouffet E, Shen WPV, Broniscer A, Bertozzi AI, Sandberg JL, Florance AM, Suttle BB, Haney P, Russo MW, Geoerger B. Phase 1 study of dabrafenib in pediatric patients (pts) with relapsed or refractory BRAF V600E high- and low-grade gliomas (HGG, LGG), Langerhans cell histiocytosis (LCH), and other solid tumors (OST). J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.10004] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | - Darren R Hargrave
- Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
| | | | | | - Ira J. Dunkel
- Memorial Sloan Kettering Cancer Center, New York, NY
| | | | | | | | | | | | - Eric Bouffet
- The Hospital for Sick Children, Toronto, ON, Canada
| | | | | | | | | | | | | | | | | | | |
Collapse
|
|
2
|
Blackman SC, Gainer SD, Suttle BB, Skordos KW, Greshock JD, Motwani M, Roadcap LT, Hardwicke MAA, Wooster RF. Abstract 1752: A phase I/IIa, first time in human, open-label dose-escalation study of GSK2636771 in subjects with advanced solid tumors with PTEN deficiency. Clin Trials 2014. [DOI: 10.1158/1538-7445.am2012-1752] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
|
3
|
McDermott DF, Infante JR, Voss MH, Motzer RJ, Haanen JBAG, Chowdhury S, Perini RF, Iannone R, Hodge R, Figueroa D, Suttle BB, Allred A, Rubin SD, Rini BI. A phase I/II study to assess the safety and efficacy of pazopanib and MK-3475 in subjects with advanced renal cell carcinoma. J Clin Oncol 2014. [DOI: 10.1200/jco.2014.32.15_suppl.tps4604] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | | | | | | | - John B. A. G. Haanen
- The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands
| | | | | | | | - Rachel Hodge
- GlaxoSmithKline Oncology, Uxbridge, United Kingdom
| | | | | | - Alicia Allred
- GlaxoSmithKline Oncology Research and Development, Early Development Unit, Research Triangle Park, NC
| | | | - Brian I. Rini
- Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
| |
Collapse
|
|
4
|
Arkenau HT, Mateo J, Lemech CR, Infante JR, Burris HA, Bang YJ, Eder JP, Herbst RS, Sharma S, Chung HC, Decordova S, Swales KE, Garrett MD, Loftiss JI, Durante M, Russo MW, Suttle BB, Motwani M, Kumar R, De Bono JS. A phase I/II, first-in-human dose-escalation study of GSK2636771 in patients (pts) with PTEN-deficient advanced tumors. J Clin Oncol 2014. [DOI: 10.1200/jco.2014.32.15_suppl.2514] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | - Joaquin Mateo
- The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
| | | | | | - Howard A. Burris
- Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN
| | - Yung-Jue Bang
- Department of Internal Medicine and Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea
| | | | | | - Sunil Sharma
- University of Utah Huntsman Cancer Institute, Salt Lake City, UT
| | - Hyun Cheol Chung
- Yonsei Cancer Center, Cancer Metastasis Research Center, Yonsei University College of Medicine, Shinchon-dong, South Korea
| | - Shaun Decordova
- The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
| | - Karen E Swales
- The Institute of Cancer Research, Sutton, United Kingdom
| | | | | | | | | | | | | | | | - Johann Sebastian De Bono
- The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
| |
Collapse
|
|
5
|
Bendell JC, Atreya CE, André T, Tabernero J, Gordon MS, Bernards R, Van Cutsem E, Tejpar S, Sidhu R, Go WY, Allred A, Motwani M, Suttle BB, Wu Y, Hoos A, Orford KW, Corcoran RB, Schellens JHM. Efficacy and tolerability in an open-label phase I/II study of MEK inhibitor trametinib (T), BRAF inhibitor dabrafenib (D), and anti-EGFR antibody panitumumab (P) in combination in patients (pts) with BRAF V600E mutated colorectal cancer (CRC). J Clin Oncol 2014. [DOI: 10.1200/jco.2014.32.15_suppl.3515] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | | | | | | | | | - Rene Bernards
- The Netherlands Cancer Institute, Amsterdam, Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
|
6
|
Kieran MW, Cohen KJ, Doz F, Dunkel IJ, Hargrave DR, Hummel TR, Jimenez I, Leary S, Pearson ADJ, Pratilas CA, Whitlock J, Durante M, Gibson DM, Haney P, Russo MW, Suttle BB, Geoerger B. Complete radiographic responses in pediatric patients with BRAFV600-positive tumors including high-grade gliomas: Preliminary results of an ongoing phase 1/2a safety and pharmacokinetics (PK) study of dabrafenib. J Clin Oncol 2014. [DOI: 10.1200/jco.2014.32.15_suppl.10056] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | | | | | - Ira J. Dunkel
- Memorial Sloan-Kettering Cancer Center, New York, NY
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|